Request for Product
-
Great Out-Licensing Opportunity for Biosimilars!
If you are interested in these opportunities, please feel free to contact DrugTimes BD Team
-
Listed Chinese pharma seeks clinical-stage innovative drugs for gynecology (non-oncological) and anti-infection; small molecules preferred
If you are interested in these opportunities, please feel free to contact DrugTimes BD Team
-
Global top pharma and VCs seek in vivo CGT platforms and therapeutic programs for for thalassemia and sickle cell anemia
If you are interested in these opportunities, please feel free to contact DrugTimes BD Team
-
Seeking innovative oral small molecules for innate immunity, indications: inflammatory & immune diseases
If you are interested in these opportunities, please feel free to contact DrugTimes BD Team
-
Licensing needs from European and US pharmaceutical enterprises & venture capital firms
If you are interested in these opportunities, please feel free to contact DrugTimes BD Team
-
Hot BD Opportunities for Molecular Glues and PROTACs!
If you are interested in this opportunity, please contact DrugTimes BD Team by email (BD@drugtimes.cn)
-
Major Chinese pharmaceutical companies in search of innovative drug assets covering oncology (solid tumors and hematological malignancies), autoimmune diseases, and central nervous system disorders
If you are interested in this opportunity, please contact DrugTimes BD Team by email (BD@drugtimes.cn)
-
Chinese Pharmaceutical Companies Seeking Antibody Assets
If you are interested in this opportunity, please contact DrugTimes BD Team by email (BD@drugtimes.cn)
-
TOP10 MNC Seeking FIC or BIC Products: Asthma
If interested, please send an email message to BD@drugtimes.cn, and indicate the project ID in the subject line
-
TOP10 MNC Seeking FIC or BIC Products: Inflammatory bowel disease (IBD)
Project ID: BP-20240430-L-EE-81 About IBD Inflammatory bowel disease (IBD) is a gro…
